down arrow

Zhejiang Anglikang Pharmaceutical Co. Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003GC2
CNY
37.71
-0.82 (-2.13%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Zhejiang Anglikang Pharmaceutical Co. Ltd.
Why is Zhejiang Anglikang Pharmaceutical Co. Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.40% and Operating profit at -16.95% over the last 5 years
2
The company has declared Negative results for the last 7 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at CNY 125.47 MM
  • ROCE(HY) Lowest at 4.32%
  • NET SALES(Q) At CNY 340.68 MM has Fallen at -15.68%
3
With ROE of 7.02%, it has a expensive valuation with a 4.52 Price to Book Value
  • Over the past year, while the stock has generated a return of 186.20%, its profits have fallen by -38.6%
  • At the current price, the company has a high dividend yield of 0.4
4
Market Beating Performance
  • The stock has generated a return of 186.20% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Zhejiang Anglikang Pharmaceutical Co. Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Anglikang Pharmaceutical Co. Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Zhejiang Anglikang Pharmaceutical Co. Ltd.
165.38%
2.48
65.70%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
2.40%
EBIT Growth (5y)
-16.95%
EBIT to Interest (avg)
71.12
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.67
Tax Ratio
1.73%
Dividend Payout Ratio
30.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.84%
ROE (avg)
10.46%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
64
Industry P/E
Price to Book Value
4.52
EV to EBIT
121.91
EV to EBITDA
50.41
EV to Capital Employed
4.72
EV to Sales
5.02
PEG Ratio
NA
Dividend Yield
0.35%
ROCE (Latest)
3.87%
ROE (Latest)
7.02%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -3.47% (YoY

-19What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 125.47 MM

ROCE(HY)

Lowest at 4.32%

NET SALES(Q)

At CNY 340.68 MM has Fallen at -15.68%

PRE-TAX PROFIT(Q)

At CNY 29.91 MM has Fallen at -47.12%

NET PROFIT(Q)

At CNY 15.91 MM has Fallen at -43.63%

Here's what is working for Zhejiang Anglikang Pharmaceutical Co. Ltd.
Raw Material Cost
Fallen by -3.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Anglikang Pharmaceutical Co. Ltd.
Net Sales
At CNY 340.68 MM has Fallen at -15.68%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY 29.91 MM has Fallen at -47.12%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 15.91 MM has Fallen at -43.63%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY 125.47 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."